[1] 中国卒中学会急救医学分会,中华医学会急诊医学分会卒中学组,中国老年医学学会急诊医学分会,等.卒中相关性肺炎诊治中国专家共识(2019更新版)[J].中国急救医学,2019,39(12):1135-1143.
[2] KISHORE A K,HEAL C,ONOCHIE-WILLIAMS A,JAMIL H,et al.Evaluation of Physiological Variables Determining Time-to-Mortality after Stroke-Associated Pneumonia[J].Cerebrovasc Dis,2024,53(Sup1):15.
[3] STANLEY D,MASON L J,MACKIN K E,et al.Translocation and dissemination of commensal bacteria in post-stroke infection[J].Nat Med,2016,22(11):1277-1284.
[4] CHUNXI L,HAIYUE L,YANXIA L,et al.The gut microbiota and respiratory diseases:new evidence[J].J Immunol Res,2020,3:2340670-2340681.
[5] MAHMOODPOOR A,HAMISHEHKARr H,ASGHARI R,et al.Effect of a probiotic reparation on ventilator‐associated pneumonia in critically ill patients admitted to the intensive care unit:a prospective double‐blind randomized controlled trial[J].NPC,2019,34(1):156-162.
[6] WANG Y,HE F,LIU B,et al.Interaction between intestinal mycobiota and microbiota shapes lung inflammation[J].Imeta,2024,3(5):e241.
[7] THANGAM T,PARTHASARATHY K,SUPRAJA K,et al.Lung Organoids:Systematic Review of Recent Advancements and its Future Perspectives[J].Tissue Eng Regen Med,2024,21(5):653-671.
[8] 何艺韵,龚亚斌,焦丽静,等.从肠道菌群微生态角度探讨“培土生金”法辨治肺癌的科学内涵[J].中医杂志,2024,65(22):2287-2293.
[9] 孟庆岩,相光鑫,颜培正,等.基于“肺合大肠”古代文献数据库的肺与大肠病理性研究[J].时珍国医国药,2016,27(12):3061-3062.
[10] 季幸姝,侯丽颖.应用蛋白质组学探讨中医“肺与大肠相表里”理论[J].中医杂志,2008,49(12):1065-1067.
[11] 姜众会,陈一帆,高铸烨.基于“肺与大肠相表里”探析肺动脉高压与肠道菌群的相关性[J/OL].中医学报,1-10[2024-12-01].http://kns.cnki.net/kcms/detail/41.1411.R.20241024.1637.026.html.
[12] 刘春艳,牛建均,柴艺汇,等.基于“肠道菌群-SCFAs-Th17/Treg细胞轴”探讨果上叶对COPD的影响[J].湖北民族大学学报(医学版),2023,40(2):65-69.
[13] 楼招欢,赵华军,吕圭源.“肺与大肠相表里”的黏膜免疫调节机制及中药干预作用研究进展[J].浙江大学学报(医学版),2020,49(6):665-678.
[14] SCHUIJT T J,LANKELMA J M,SCICLUNA B P,et al.The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia[J].Gut,2016,65(4):575-583.
[15] BUDDEN K F,GELLATLY S L,WOOD DLA,et al.Emerging pathogenic links between microbiota and the gut-lung axis[J].Nat Rev Microbiol,2017,15(1):55-63.
[16] MEHMOOD QADRI H,DAR S A,BASHIR R A,et al.Gastrointestinal Dysbiosis in Neuro-Critically Ill Patients:A Systematic Review of Case-Control Studies[J].Cureus,2023,15(12):11.
[17] GRIER A,MCDAVID A,WANG B,et al.Neonatal gut and respiratory microbiota:coordinated development through time and space[J].Microbiome,2018,6(1):193.
[18] AGIRMAN G,YU K B,HSIAO E Y.Signaling inflammation across the gut-brain axis[J].Science,2021,374(6571):1087-1092.
[19] FAURA J,BUSTAMANTE A,MIRó-MUR F,et al.Stroke-induced immunosuppression:implications for the prevention and prediction of post-stroke infections[J].J Neuroinflammation,2021,18(1):127.
[20] WANG R H,WEN X,JIANG Z P,et al.The Clinical Value of Neutrophil-to-Lymphocyte Ratio(NLR),Systemic Immune Inflammation Index(SII),Platelet-to-Lymphocyte Ratio(PLR) and Systemic Inflammation Response Index(SIRI)for Predicting the Occurrence and Severity of Pneumonia in Patients with Intra cerebral Hemorrhage[J].Front Immunol,2023,14:1115031.
[21] HUANG Q,XIA J.Influence of the gut microbiome on inflammatory and immune response after stroke[J].Neurol Sci,2021,42(12):4937-4951.
[22] JAMBO K C,SEPAKO E,HEYDRMAN R S,et al.Potential role for mucosally active vaccines against pneumococcal pneumonia[J].Trends Microbiol,2010,18(2):81-89.
[23] PEH A,O’DONNELL J A,BROUGHTON BR S,et al.Gut microbiota and their metabolites in stroke:a double-edged sword[J].Stroke,2022,53(5):1788-1801.
[24] KIM,C H.Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity[J].Cell Mol Immunol,2023,20(4):341-350.
[25] GUO C,HUO Y J,LI Y,et al.Gut-brain axis:Focus on gut metabolites short-chain fatty acids[J].World J Clin Cases,2022,10(6):1754-1763.
[26] CHEN X,HU Y,YUAN X,et al.Effect of early enteral nutrition combined with probiotics in patients with stroke:a meta-analysis of randomized controlled trials[J].EJCN,2022,76(4):592-603.
[27] 周正任. 医学微生物学[M].北京:人民卫生出版社,2008:87.
[28] STUTZ M R,DYLLA N P,PEARSON S D,et al.Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure[J].Nat Commun,2022,13(1):6615.
[29] 任星. 基于脑肠轴理论加味星蒌承气汤治疗急性脑梗死(痰热腑实型)的临床观察[D].济南:山东中医药大学,2023.
[30] 吴欣尧,林才志,刘云平,等.参苓白术散治疗大肠相关性疾病的研究进展[J].实用中医内科杂志,2025,39(1):34-37.
[31] 滕晋,王丹,向露,等.参苓白术颗粒预防老年抗生素相关性肠道菌群失调的RCT研究[J].成都中医药大学学报,2015,38(3):52-54.
[32] 姜华,邓松华.增液承气汤对肠道菌群失调大鼠神经肽分泌调节影响研究[J].四川中医,2018,36(10):46-48.
[33] 马丽琼,段金旗,于明克.大黄对脓毒症大鼠胃肠道菌群的影响[J].中华临床医师杂志(电子版),2012,6(10):2790-2792.
[34] 陈德昌,马丽琼,刘绍泽.大黄对脓毒症大鼠肠道细菌及其移位的影响[J].中国危重病急救医学,2009,21(1):17-20. |
